» Articles » PMID: 29051843

Alterations in Micro RNA-messenger RNA (miRNA-mRNA) Coupled Signaling Networks in Sporadic Alzheimer's Disease (AD) Hippocampal CA1

Overview
Date 2017 Oct 21
PMID 29051843
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

RNA sequencing, DNA microfluidic array, LED-Northern, Western immunoassay and bioinformatics analysis have uncovered a small family of up-regulated human brain enriched microRNAs (miRNAs) and down-regulated messenger RNAs (mRNAs) in short post-mortem interval (PMI) sporadic Alzheimer's disease (AD) brain. At the mRNA level, a large majority of the expression of human brain genes found to be down-regulated in sporadic AD appears to be a consequence of an up-regulation of a specific group of NF-kB-inducible microRNAs (miRNAs). This group of up-regulated miRNAs - including miRNA-34a and miRNA-146a - has strong, energetically favorable, complimentary RNA sequences in the 3' untranslated regions (3'-UTR) of their target mRNAs which ultimately drive the down-regulation in the expression of certain essential brain genes. Interestingly, just 2 significantly up-regulated miRNAs - miRNA-34a and miRNA-146a - appear to down-regulate mRNA targets involved in synaptogenesis (SHANK3), phagocytosis deficits and tau pathology (TREM2), inflammation (CFH; complement factor H) and amyloidogenesis (TSPAN12), all of which are distinguishing pathological features characteristic of middle-to-late stage AD neuropathology. This paper reports the novel finding of parallel miRNA-34a and miRNA-146a up-regulation in sporadic AD hippocampal CA1 RNA pools and proposes an altered miRNA-mRNA coupled signaling network in AD, much of which is supported by current experimental findings in the recent literature.

Citing Articles

Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases.

Yashooa R, Duranti E, Conconi D, Lavitrano M, Mustafa S, Villa C Int J Mol Sci. 2025; 26(2).

PMID: 39859339 PMC: 11766038. DOI: 10.3390/ijms26020626.


Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine.

Long J, Zhang J, Zeng X, Wang M, Wang N CNS Neurosci Ther. 2024; 30(11):e70101.

PMID: 39508315 PMC: 11541599. DOI: 10.1111/cns.70101.


The complex effects of miR-146a in the pathogenesis of Alzheimer's disease.

Long Y, Liu J, Wang Y, Guo H, Cui G Neural Regen Res. 2024; 20(5):1309-1323.

PMID: 39075895 PMC: 11624861. DOI: 10.4103/NRR.NRR-D-23-01566.


MicroRNA (miRNA) Complexity in Alzheimer's Disease (AD).

Lukiw W Biology (Basel). 2023; 12(6).

PMID: 37372073 PMC: 10295300. DOI: 10.3390/biology12060788.


MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer's disease.

Wijesinghe P, Xi J, Cui J, Campbell M, Pham W, Matsubara J Life Sci Alliance. 2023; 6(6).

PMID: 36941055 PMC: 10027899. DOI: 10.26508/lsa.202201757.


References
1.
Jang S, Chung H . Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity. Neural Plast. 2016; 2016:7969272. PMC: 4785275. DOI: 10.1155/2016/7969272. View

2.
Skaper S, Facci L, Zusso M, Giusti P . Synaptic Plasticity, Dementia and Alzheimer Disease. CNS Neurol Disord Drug Targets. 2017; 16(3):220-233. DOI: 10.2174/1871527316666170113120853. View

3.
Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

4.
Zhao Y, Bhattacharjee S, Dua P, Alexandrov P, Lukiw W . microRNA-Based Biomarkers and the Diagnosis of Alzheimer's Disease. Front Neurol. 2015; 6:162. PMC: 4499702. DOI: 10.3389/fneur.2015.00162. View

5.
Lukiw W . NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol. 2011; 235(2):484-90. PMC: 3321120. DOI: 10.1016/j.expneurol.2011.11.022. View